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ABSTRACT
Objectives To report the rate of additional central
nervous system (CNS) anomalies detected exclusively
on prenatal magnetic resonance imaging (MRI) in
fetuses diagnosed with isolated mild or moderate
ventriculomegaly (VM) on ultrasound, according to
the type of ultrasound protocol adopted (dedicated
neurosonography vs standard assessment of the fetal
brain), and to explore whether the diagnostic performance
of fetal MRI in detecting such anomalies is affected by
gestational age at examination and laterality and degree
of ventricular dilatation.
Methods MEDLINE, EMBASE, CINAHL and
Clinicaltrials.gov were searched for studies report-
ing on the prenatal MRI assessment of fetuses diagnosed
with isolated mild or moderate VM (ventricular dilatation
of 10–15 mm) on ultrasound. Additional anomalies
detected only on MRI were classified as callosal,
septal, posterior fossa, white matter, intraventricu-
lar hemorrhage, cortical, periventricular heterotopia,
periventricular cysts or complex malformations. The rate
of additional anomalies was compared between fetuses
diagnosed on dedicated neurosonography, defined as a
detailed assessment of the fetal brain, according to the
International Society of Ultrasound in Obstetrics and
Gynecology guidelines, and those diagnosed on standard
fetal brain assessment. The rate of additional CNS
anomalies missed on prenatal MRI and detected only at
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birth was calculated and compared between fetuses that
had early (at or before 24 weeks’ gestation) and those
that had late (after 24 weeks) MRI. Subanalysis was
performed according to the laterality (uni- vs bilateral)
and degree (mild vs moderate, defined as ventricular
dilatation of 10–12 and 13–15 mm, respectively) of
ventricular dilatation. Whether MRI assessment led to a
significant change in prenatal management was explored.
Random-effects meta-analysis of proportions was used.
Results Sixteen studies (1159 fetuses) were included
in the systematic review. Overall, MRI detected an
anomaly not identified on ultrasound in 10.0% (95% CI,
6.2–14.5%) of fetuses. However, when stratifying the
analysis according to the type of ultrasound assessment,
the rate of associated anomalies detected only on
MRI was 5.0% (95% CI, 3.0–7.0%) when dedicated
neurosonography was performed compared with 16.8%
(95% CI, 8.3–27.6%) in cases that underwent a standard
assessment of the fetal brain in the axial plane. The
overall rate of an additional anomaly detected only at
birth and missed on prenatal MRI was 0.9% (95% CI,
0.04–1.5%) (I2, 0%). There was no difference in the rate
of an associated anomaly detected only after birth when
fetal MRI was carried out before, compared with after,
24 weeks of gestation (P = 0.265). The risk of detecting
an associated CNS abnormality on MRI was higher
in fetuses with moderate than in those with mild VM
(odds ratio, 8.1 (95% CI, 2.3–29.0); P = 0.001), while
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there was no difference in those presenting with bilateral,
compared with unilateral, dilatation (P = 0.333). Finally,
a significant change in perinatal management, mainly
termination of pregnancy owing to parental request,
following MRI detection of an associated anomaly, was
observed in 2.9% (95% CI, 0.01–9.8%) of fetuses
undergoing dedicated neurosonography compared with
5.1% (95% CI, 3.2–7.5%) of those having standard
assessment.
Conclusions In fetuses undergoing dedicated neuro-
sonography, the rate of a CNS anomaly detected
exclusively on MRI is lower than that reported previously.
Early MRI has an excellent diagnostic performance
in identifying additional CNS anomalies, although
the findings from this review suggest that MRI performed
in the third trimester may be associated with a better
detection rate for some types of anomaly, such as cortical,
white matter and intracranial hemorrhagic anomalies.
Copyright ! 2018 ISUOG. Published by John Wiley &
Sons Ltd.
INTRODUCTION
Ventriculomegaly (VM) encompasses a spectrum of con-
ditions characterized by dilatation of the lateral ventricles
of the brain, typically defined as > 10 mm at the level
of the atria, with or without dilatation of the third or
fourth ventricle1–4. VM is the most common prenatally
diagnosed fetal brain anomaly, with a reported prevalence
ranging from 1:1600 to 1:50 newborns1–4.
VM is commonly categorized, according to the degree
of ventricular dilatation, as mild (10–12 mm), moderate
(13–15 mm) or severe (> 15 mm); the rationale for such
classification relies on the fact that the risk of associated
anomalies and abnormal neurodevelopmental outcome
is higher with increasing degree of dilatation5. VM is not
a unique condition, but rather a sonographic sign that
represents a common endpoint of various pathological
processes with different outcomes and prognoses; it may
also be a physiological finding representing extreme
normal variation6–8.
The main determinants of postnatal outcome in
fetuses presenting with VM are the etiology, presence
of associated anomalies and severity of ventricular
dilatation. Thus, the main issues to be resolved during
the diagnostic work-up of a fetus with VM are ruling
out infection and chromosomal, central nervous system
(CNS) and non-CNS anomalies7.
Fetal magnetic resonance imaging (MRI) has been
shown to add additional information compared with
ultrasound in fetuses affected by a CNS anomaly9.
The overall prevalence of additional brain abnormalities
detected prenatally by MRI has been reported to be as
high as 19% in fetuses with VM, irrespective of the degree
of ventricular dilatation10. However, the majority of these
studies do not report the type of ultrasound assessment
performed, and the MRI scans were performed at different
gestational ages. The International Society of Ultrasound
in Obstetrics and Gynecology (ISUOG) recommends that
fetuses presenting with a CNS anomaly should undergo
multiplanar assessment of the brain in axial, coronal and
sagittal views of the fetal head11. Therefore, it is plausible
that the rate of associated anomalies detected exclusively
on MRI reported in the published literature may be
affected by the type of ultrasound assessment performed.
The primary aim of this systematic review was to report
the rate of additional anomalies detected exclusively on
prenatal MRI in fetuses diagnosed with isolated VM on
ultrasound, according to the type of ultrasound protocol
adopted. The secondary aim was to explore whether the
diagnostic performance of fetal MRI in detecting such
anomalies is affected by gestational age at examination.
METHODS
Protocol, eligibility criteria, information sources and
search
This review was performed according to an a-priori
designed protocol recommended for systematic reviews
and meta-analyses12–14. MEDLINE, EMBASE, CINAHL
and Clinicaltrials.gov databases were searched electron-
ically in June 2018, utilizing combinations of the relevant
medical subject heading (MeSH) terms, keywords and
word variants for ‘magnetic resonance imaging’ and
‘ventriculomegaly’ (Table S1). The search and selection
criteria were restricted to the English language. Refer-
ence lists of relevant articles and reviews were hand
searched for additional reports; PRISMA and MOOSE
guidelines were followed15–17. The study was registered
with the PROSPERO database (registration number:
CRD42018104173).
Study selection, data collection and data items
The primary aim of this study was to report the rate
of additional anomalies detected exclusively on prenatal
MRI in fetuses affected by isolated mild or moderate VM,
defined as ventricular dilatation of 10–15 mm, under-
going, compared with those not undergoing, dedicated
neurosonography, defined as a detailed assessment of the
fetal brain in axial, sagittal and coronal views, according
to ISUOG guidelines11.
Additional anomalies were classified as: callosal
anomalies, including complete and partial agenesis,
hypoplasia and dysgenesis of the corpus callosum; septal
anomalies, including all abnormalities characterized by
a primary defect involving the septum pellucidum with
a normally present corpus callosum; posterior fossa
anomalies, including all defects involving the cerebellar
vermis and/or hemispheres; intraventricular hemorrhage;
cortical anomalies, including all abnormalities associated
with a primary defect in neuronal migration towards the
cortical surface of the brain; periventricular heterotopia;
other white-matter anomalies; periventricular cysts; com-
plex brain anomalies, including all defects characterized
by the presence of multiple intracranial anomalies; and
other cerebral anomalies.
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For the purpose of the analysis, we did not consider
as associated anomalies biometric variation in brain
structure, such as mega cisterna magna, or increased or
reduced degree of ventricular dilatation or of cranial size.
Furthermore, we aimed at performing a subgroup analysis
according to the laterality (unilateral vs bilateral VM) and
degree (mild (10–12 mm) vs moderate (13–15 mm)) of
ventricular dilatation.
Our secondary aim was to elucidate whether the
diagnostic performance of fetal MRI for the detection of
additional CNS anomalies was affected by gestational age
at scan. For the purpose of the analysis, we calculated the
rate of additional CNS anomalies missed on prenatal MRI
and detected only at birth in fetuses that had early (at or
before 24 weeks’ gestation) compared with those that had
late (after 24 weeks) MRI. Finally, we explored whether
MRI detection of associated anomalies led to a change in
the prenatal management of the pregnancy, mainly defined
as termination of pregnancy (TOP) at parental request
owing to the higher risk of abnormal neurodevelopmental
outcome in fetuses with an associated anomaly detected
on MRI.
Only studies reporting the prevalence of brain
anomalies diagnosed on MRI in fetuses affected by
isolated VM confirmed on postnatal imaging, or
postmortem examination in case of TOP or fetal demise,
were considered eligible for inclusion in this systematic
review. VM was defined as isolated when no other CNS
or non-CNS anomalies were detected on ultrasound.
Studies including cases with a fetal anomaly, those
including exclusively cases of severe VM (defined as
ventricular dilatation > 15 mm) and those not reporting
the degree of ventricular dilatation were excluded in view
of the higher risk of associated brain anomalies in cases
presenting with additional anomalies and/or severe VM.
Case reports, conference abstracts and case series with
fewer than three cases were excluded to avoid publication
bias. Furthermore, studies published before the ISUOG
guidelines recommending a detailed assessment of the
fetal brain (2007)11 were also excluded, as advances
in prenatal imaging and difficulties in extrapolating
the type of ultrasound protocol used make them less
relevant.
Two authors (D.D.M., F.G.S.) independently reviewed
all abstracts. Agreement regarding potential relevance
was reached by consensus or resolved by discussion
with a third reviewer (F.D.A.). Full-text copies of those
papers deemed to be relevant were obtained, and the same
reviewers independently extracted relevant data regarding
study characteristics and pregnancy outcomes. Consensus
on inconsistencies was reached by discussion by the two
reviewers or with a third author. If more than one study
had been published on the same cohort with identical
endpoints, the report containing the most comprehensive
information on the population was included to avoid
overlapping populations. For those articles in which
information was not reported but the methodology was
such that this information would have been recorded
initially, the authors were contacted.
Quality assessment of the included studies was
performed using the Newcastle–Ottawa Scale (NOS)
for cohort studies. According to the NOS, each study
is judged on three broad perspectives: selection of
the study groups, comparability of the groups and
ascertainment of the outcome of interest18. Assessment of
the selection of the groups in a study includes evaluation
of the representativeness of the exposed cohort, selection
of the non-exposed cohort, ascertainment of exposure
and demonstration that the outcome of interest was
not present at the start of the study. Assessment of
comparability of the study groups includes evaluation
of the comparability of cohorts based on the design
or analysis. Finally, assessment of ascertainment of the
outcome of interest includes evaluation of the type of
assessment of the outcome of interest and length and
adequacy of follow-up. According to the NOS, a study
can be awarded a maximum of one star for each numbered
item within the selection and outcome categories; a
maximum of two stars can be given for comparability18.
Statistical analysis
First, random-effects meta-analysis of proportions was
used to estimate the pooled rates of each brain anomaly
in fetuses diagnosed with isolated VM undergoing
MRI assessment. Second, random-effects head-to-head
meta-analysis was used to compare directly the risk of
detecting an associated anomaly in fetuses undergoing
early (! 24 weeks) compared with those undergoing
late (> 24 weeks) fetal MRI, expressing the results
as a summary odds ratio (OR) and 95% CI, and
evaluating statistical heterogeneity using the I2 metric.
Data from individual studies were also combined to
estimate the weighted mean gestational age at diagnosis
of brain anomalies among fetuses with VM detected
using the multiplanar approach. Only sparse data
on gestational age were available in the standard
ultrasound group, as well as on the time interval between
ultrasound and MRI examinations in both groups. In
these cases, no meta-analyses were performed and the
results were reported only narratively for descriptive
purposes. All included studies reported single-group
analyses, and no outcome comparison between groups
was available, thus no head-to-head meta-analysis could
be performed.
Publication bias was assessed graphically using funnel
plots, and formally using Egger’s regression asymmetry
test; formal tests for funnel-plot asymmetry were not
performed when the total number of publications included
for each outcome was less than 10 because in such cases
the power of the test would be too low to distinguish
chance from real asymmetry.
Both proportion and single-group meta-analyses of
continuous data were performed using a random-effects
model to account for interstudy heterogeneity. All
analyses were carried out using Stata version 13.1 (Stata
Corp., College Station, TX, USA, 2013).
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RESULTS
General characteristics
Six hundred and twenty articles were identified, of which
66 were assessed with respect to their eligibility for inclu-
sion (Table S2) and 16 were included in the systematic
review (Tables 1 and S3 and Figure 1)19–34. These sixteen
studies included 1159 fetuses diagnosed with isolated
mild or moderate VM. The diagnosis of isolated VM was
based on multiplanar neurosonography in eight studies
(596 fetuses), while a standard axial assessment of the
fetal brain was used in the remaining eight studies (563
fetuses). Mean gestational age at MRI was 27.2 weeks
(95% CI, 26.8–27.6 weeks) in fetuses undergoing neu-
rosonography compared with 27.1 weeks (95% CI,
26.9–27.3 weeks) in those having standard assessment.
Associated anomalies confirmed at birth or on autopsy
were found in 8.6% (95% CI, 7.1–10.4%) of cases with
a prenatal diagnosis of isolated VM on ultrasound.
The results of the quality assessment of the included
studies using the NOS are presented in Table 2. Most
of the included studies showed an overall good score
regarding the selection and comparability of the study
groups and ascertainment of the outcome of interest.
The main weaknesses of the studies were their retro-
spective design, small sample size, different gestational
ages at examination and lack of stratification of the
results according to laterality and degree of ventricular
dilatation in most of the included studies. Furthermore,
stratification of the analysis according to gestational age
at MRI was possible only by adopting a single cut-off














































Figure 1 Flowchart summarizing inclusion of studies on prenatal
magnetic resonance imaging assessment of fetuses diagnosed with
isolated mild or moderate ventriculomegaly on ultrasound.
Table 1 Summary of characteristics of included studies reporting on prenatal magnetic resonance imaging (MRI) assessment of fetuses


























Griffiths (2017)19 UK Prosp 2011–2014 280 NS Max 14 days NS No 1.5 T 10–15 US, MRI, CT
Lavongtheung (2018)20 France Retro 2011–2015 14 31 Max 9 weeks NS No 1.5 T 10–12 US, MRI
Mehlhorn (2017)21 USA Retro 2009–2015 24 29.7 Max 5 weeks TA No 1.5 T 10–15 NS
Gezer (2016)22 Turkey Retro 2007–2009 14 NS NS NS No 1.5 T 10–15 US, MRI, CT
Tonni (2016)23 Italy Prosp 2007–2010 54 26.6 Mean 1 week NS Yes 1.5 T 10–15 US, MRI




TA Yes 1.5 T 10–15 US, MRI
Kandula (2015)25 Australia Prosp 2006–2013 52 28
[25.3–32]
Median 2 weeks NS No 1.5 T 10–15 NS
Paladini (2014)26 Italy Retro 2005–2012 30 27
(21–36)
Max 1 week TA and TV Yes 1.5 T 10–15 US, MRI, CT
Pasquini (2014)27 Italy Retro 2007–2012 132 30.16 Mean 3.7 weeks TA and TV Yes 1.5 T 10–15 US, MRI
Parazzini (2012)28 Italy Retro 2003–2010 179 26 ± 4.2 Mean 7.6 days TA and TV Yes 1.5 T 10–12 US, MRI, CT
Miguelote (2012)29 Portugal Prosp 2010–2011 18 NS NS NS Yes 1.5 T 10–15 US, MRI
Han Huang (2013)30 Taiwan Retro 2003–2010 42 NS NS NS NS 1.5 T 10–15 NS
Griffiths (2010)31 UK Prosp 2005–2009 119 NS Max 4 days NS NS 1.5 T 10–12 NS
Yin (2010)32 China Prosp 2006–2008 51 31–38 NS TA Yes 1.5 T 10–12 NS
Benacerraf (2007)33 USA Prosp NS 14 24.14 ±
5.02
NS TA and TV Yes 1.5 T 10–12 NS
Morris (2007)34 UK Retro 1999–2003 18 22.8 Max 4 days NS No 1.5 T 10–15 NS
Only first author of each study is given. *Data are mean, mean (range), median [interquartile range], mean ± SD or range. †Maximum
(Max), mean or median interval. CT, computed tomography; GA, gestational age; NS, not stated; Prosp, prospective; Retro, retrospective;
TA, transabdominal; TV, transvaginal; US, ultrasound.
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Table 2 Quality assessment on Newcastle–Ottawa Scale of
included studies reporting on prenatal magnetic resonance imaging
assessment of fetuses diagnosed with isolated mild or moderate
ventriculomegaly on ultrasound
Study Selection Comparability Outcome
Griffiths (2017)19 !! ! !!
Lavongtheung (2018)20 !! ! !!
Mehlhorn (2017)21 !! ! !!
Gezer (2016)22 !! ! !!
Tonni (2016)23 !! ! !!
Baffero (2015)24 !! ! !!
Kandula (2015)25 !! ! !
Paladini (2014)26 !! !! !!
Pasquini (2014)27 !! ! !!
Parazzini (2012)28 !! ! !!
Miguelote (2012)29 !! ! !
Han Huang (2013)30 !! ! !
Griffiths (2010)31 !! ! !!
Yin (2010)32 !! ! !!
Benacerraf (2007)33 !! ! !!
Morris (2007)34 !! ! !!
Only first author of each study is given. A study can be awarded a
maximum of one star for each numbered item within the selection
and outcome categories. A maximum of two stars can be given for
comparability.
any meaningful subanalysis according to time interval
between ultrasound and MRI assessments.
Synthesis of results
Sixteen studies19–34 (1159 fetuses) explored the role of
fetal MRI in detecting associated anomalies in fetuses
with a prenatal diagnosis of isolated VM on ultrasound.
Overall, MRI detected 10.0% (95% CI, 6.2–14.5%); (I2,
78.7%; 92/1159 fetuses) of fetal anomalies not detected
on ultrasound. However, when stratifying the analysis
according to the type of ultrasound assessment, the rate
of associated anomalies detected only on MRI was 5.0%
(95% CI, 3.0–7.0%) (I2, 5.9%; 28/596 fetuses) when
dedicated neurosonography was performed, compared
with 16.8% (95% CI, 8.3–27.6%) (I2, 86.1%; 64/563
fetuses) in cases diagnosed on standard assessment of the
fetal brain in the axial plane (Figure 2).
When stratifying the analysis according to the type of
anomaly detected on MRI, the incidence of a callosal
anomaly undetected on ultrasound was 0.7% (95% CI,
0.2–1.5%) in fetuses that underwent neurosonography
and 2.9% (95% CI, 1.1–5.7%) in those that had standard
assessment of the fetal brain, while the corresponding
figures for a posterior fossa anomaly were 0.4% (95%
CI, 0.1–1.1%) and 0.9% (95% CI, 0.2–2.1%) (Table 3).
Cortical anomalies missed on ultrasound were detected
on MRI in 1.6% (95% CI, 0.9–2.3%) of fetuses with a
prenatal diagnosis of isolated VM, with no difference
between cases that underwent neurosonography and
those that had standard assessment of the fetal brain
(pooled proportions (PP), 1.6% (95% CI, 0.7–2.7%) vs
1.5% (95% CI, 0.7–2.7%)). Hemorrhagic lesions were
missed on ultrasound and detected exclusively on MRI
in 1.1% (95% CI, 0.3–2.4%) of cases that underwent
detailed neurosonography and 2.0% (95% CI, 0.6–4.1%)
of those that received standard assessment. Finally,
white-matter anomalies were missed on ultrasound and
detected on MRI in 1.4% (95% CI, 0.6–2.5%) of cases
with an ultrasound diagnosis of isolated VM overall, in
1.6% (95% CI, 0.7–2.7%) of those that had detailed
neurosonography and in 1.8% (95% CI, 0.3–4.4%) of
those that had a standard ultrasound assessment.
The overall rate of an additional anomaly detected only
at birth and missed on prenatal MRI was 0.9% (95%
CI, 0.04–1.5%) (I2, 0%). The rate of an associated CNS
anomaly missed on prenatal MRI and diagnosed only at
birth was 1.3% (95% CI, 0.5–2.4%) when MRI was
performed before 24 weeks’ gestation and 0.8% (95%
CI, 0.3–1.7%) when carried out after 24 weeks, with no
significant difference between the two groups (OR, 2.3
(95% CI, 0.5–9.9) (I2, 0%; P = 0.265)).
Subanalyses including only fetuses undergoing multi-
planar assessment of the brain were performed according
to degree of ventricular dilatation and laterality (Tables S4
and S5). The risk of detecting an associated CNS anomaly
on MRI was higher in fetuses with moderate VM (PP,
22.6% (95% CI, 11.1–36.7%)) than in those with mild
VM (PP, 3.5% (95% CI, 1.7–6.1%)) (OR, 8.1 (95%
CI, 2.3–29.0) (I2, 18.1%; P = 0.001)), while there was
no difference in those presenting with bilateral VM (PP,
7.2% (95% CI, 3.3–12.3%) (I2, 46.7%)) compared to
those with unilateral VM (PP, 3.0% (95% CI, 0.8–6.3%)
(I2, 0%)) (OR, 1.8 (95% CI, 0.6–5.4) (I2, 8.1%;
P = 0.333)).
Finally, the rate of the change in perinatal management
after prenatal MRI was explored. Overall, 4.6% (95%
CI, 2.1–8.0%) (I2, 61%) of fetuses with a prenatal
diagnosis of isolated VM on ultrasound had a significant
change in perinatal management, mainly TOP at parental
request, following detection of an associated anomaly
on MRI. When stratifying the analysis according
to the type of ultrasound assessment performed, a
significant change in perinatal management involved
2.9% (95% CI, 0.01–9.8%) (I2, 65.3%) of fetuses that
underwent neurosonography compared with 5.1% (95%




The findings from this systematic review show that,
in fetuses affected by VM undergoing dedicated neuro-
sonography, the rate of a CNS anomaly detected exclu-
sively on MRI is lower than has been reported previously.
Fetal MRI has a high diagnostic accuracy in identify-
ing associated anomalies regardless of gestational age
at MRI. Furthermore, the risk of detecting associated
anomalies is higher in fetuses with moderate, compared
to those with mild, VM, while there was no differ-
ence between cases with unilateral, compared to those
with bilateral, VM.
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Figure 2 Pooled rates of additional brain anomalies detected on magnetic resonance imaging in fetuses diagnosed with isolated mild or
moderate ventriculomegaly on multiplanar neurosonography (a) and standard ultrasound assessment of brain (b).
Table 3 Pooled proportions of rate of additional central nervous system (CNS) anomalies detected on magnetic resonance imaging in fetuses
with prenatal diagnosis of isolated mild or moderate ventriculomegaly on ultrasound, according to ultrasound assessment


























Callosal 16 15/1159 1.42 (0.7–2.4) 26.0 8 2/596 0.67 (0.2–1.5) 0 8 13/563 2.92 (1.1–5.7) 46.3
Septal 16 2/1159 0.45 (0.1–0.9) 0 8 0/596 0 (0–0.9) 0 8 2/563 0.66 (0.2–1.5) 0
Posterior fossa 16 5/1159 0.56 (0.2–1.1) 5.8 8 2/596 0.44 (0.1–1.1) 0.8 8 3/563 0.85 (0.2–2.1) 19.7
Hemorrhage 16 14/1159 1.43 (0.6–2.5) 35.4 8 5/596 1.07 (0.3–2.4) 32.1 8 9/563 1.97 (0.6–4.1) 39.2
Cortical 16 15/1159 1.55 (0.9–2.3) 0 8 8/596 1.56 (0.7–2.7) 0 8 7/563 1.53 (0.7–2.7) 0
Periventricular
heterotopia
16 0/1159 0 (0–0.7) 0 8 0/596 0 (0–0.9) 0 8 0/563 0 (0–0.9) 0
White matter 16 15/1159 1.39 (0.6–2.5) 32.8 8 8/596 1.57 (0.7–2.7) 0 8 7/563 1.75 (0.3–4.4) 57.9
Periventricular
cyst
16 2/1159 0.41 (0.1–0.9) 0 8 1/596 0.45 (0.01–1.1) 0 8 1/563 0.36 (0.03–1.0) 0
Complex 16 8/1159 0.85 (0.4–1.5) 0 8 1/596 0.44 (0.01–1.1) 0 8 7/563 1.55 (0.7–2.7) 0
Other 16 16/1159 1.68 (0.5–3.5) 67.9 8 1/596 0.38 (0.001–1.0) 0 8 15/563 4.03 (0.7–9.9) 82.8
Data in parentheses are 95% CI.
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Limitations of the study
Retrospective design, small sample size, different gesta-
tional ages at examination and lack of stratification of the
results according to laterality and degree of ventricu-
lar dilatation in most of the included studies represent
the main limitations of this systematic review. Further-
more, not all cases presenting an additional anomaly
on MRI were screened for aneuploidy or infection.
In this scenario, it might be possible that some cases
affected by aneuploidy or infection diagnosed only later
on after birth were included in the analysis, thus affect-
ing the robustness of the results. Finally, it was not
possible to rule out completely inclusion of cases compli-
cated by maternal medical conditions potentially leading
to an increased risk of associated CNS anomalies in the
setting of VM, which may explain the relatively high inci-
dence of acquired brain anomalies, such as hemorrhage,
reported in this review.
Implications for clinical practice and research
Ruling out associated anomalies in fetuses with a
prenatal diagnosis of VM is fundamental, as the
neurodevelopmental outcome of these children is greatly
affected by the presence of associated malformations.
ISUOG recommends that fetuses presenting with a CNS
anomaly should undergo a multiplanar assessment of the
fetal head in order to rule out associated anomalies that
may be missed on a standard assessment. Likewise, the
Society for Maternal–Fetal Medicine suggests that MRI
should be considered in cases of mild or moderate fetal
VM, although it may be of less value if the woman has
had a detailed ultrasound examination performed by an
individual with specific experience of, and expertise in,
sonographic imaging of the fetal brain. These statements
from two key maternal–fetal medicine societies highlight
the need for a detailed assessment of the fetal brain
when VM is detected on a scan. Despite this, it
is common clinical practice to refer pregnancies with
fetuses presenting with VM for MRI without a detailed
assessment of the brain. This has led to a high reported
incidence of associated anomalies detected only on MRI
in fetuses presenting with isolated VM on ultrasound.
In the present review, the large majority of associated
malformations undetected on ultrasound in cases under-
going standard assessment comprised a callosal anomaly.
This emphasizes the need for detailed neurosonography
in fetuses presenting with ventricular dilatation in axial
views in order to reduce the number of cases classified
incorrectly as isolated VM. This is also fundamental, as
fetal MRI may not be available immediately and a late
diagnosis of an associated anomaly may lead to increased
parental stress and a lack of legal options in the prenatal
management of the pregnancy. This is also highlighted by
the different amounts of change in prenatal management
after MRI in fetuses undergoing, compared with those not
undergoing, neurosonography.
It has been suggested that fetal MRI has a high
diagnostic accuracy in detecting cortical malformations,
such as polymicrogyria and schizencephaly10,35. The true
prevalence of congenital cortical anomalies in the general
population is largely unknown and some of these cases are
suspected on fetal ultrasound during the third trimester of
pregnancy based on the subjective findings of immature
sulcation, thin and smooth cortex or wide and thick
gyri. In the present systematic review, the rate of cortical
anomalies detected exclusively on MRI was about 1.6%,
highlighting the need for a detailed MRI assessment of
the fetal brain in order to rule out such anomalies.
The severity of ventricular dilatation is associated
with an increasing risk of adverse neurodevelopmental
outcome in fetuses presenting with isolated VM. In
the present systematic review, the rate of an associated
anomaly detected only on MRI was 3.5% and 22.6%
in cases with mild and moderate VM, respectively, sug-
gesting that increasing ventricular dilatation is associated
with a higher risk of an associated anomaly. Conversely,
there was no difference in the rate of associated anomalies
detected only on MRI in fetuses with unilateral, compared
to those with bilateral, VM, although the very small
number of cases included in this subanalysis may have
led to a lack of statistical power.
Gestational age at MRI is another important clinical
factor when assessing fetuses with an ultrasound diagnosis
of isolated VM. Early (second-trimester) MRI assessment
is useful to confirm the diagnosis and rule out associated
anomalies, especially in those countries in which TOP
beyond the second trimester is not allowed, although it
may overlook anomalies such as cortical malformations
or hemorrhage, which become evident only later on in ges-
tation. In this systematic review, the overall rate of addi-
tional anomalies detected only at birth and missed on pre-
natal MRI was 1.3% (95% CI, 0.5–2.4%) when MRI was
performed before, and 0.8% (95% CI, 0.3–1.7%) when
carried out after, 24 weeks’ gestation. Although there was
no statistical difference in the rates of undetected CNS
anomalies between fetuses that had early, and those that
had late, MRI, it would be reasonable to perform MRI in
the third trimester of pregnancy, as most of the anomalies
coexisting with VM, such as cortical, white matter or
hemorrhage, become more evident after 24 weeks’ gesta-
tion. However, parents should be reassured that, in cases
in which VM is apparently isolated on fetal MRI, the
probability of an undetected anomaly at birth is low.
Conclusions
Fetuses diagnosed with isolated VM on ultrasound screen-
ing examination should be referred for dedicated neuro-
sonography in order to rule out associated anomalies
that may affect the short- and long-term neuro-
developmental outcome of these children. MRI assess-
ment of these fetuses is recommended to detect associated
anomalies that may be missed on neurosonography in
about 5% of cases. Although early MRI is reliable, a
third-trimester ultrasound scan may detect conditions
potentially missed on a second-trimester scan, such as
hemorrhage. In the future, large prospective studies
Copyright ! 2018 ISUOG. Published by John Wiley & Sons Ltd. Ultrasound Obstet Gynecol 2019; 54: 164–171.
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sharing objective protocols for ultrasound imagining of
the fetal brain are needed to elucidate better the actual
role of fetal MRI when fetal neurosonography has been
performed.
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SUPPORTING INFORMATION ON THE INTERNET
The following supporting information may be found in the online version of this article:
Table S1 Search strategy for studies reporting on prenatal MRI assessment of fetuses diagnosed with isolated mild or moderate
ventriculomegaly on ultrasound
Table S2 Excluded studies and reason for exclusion
Table S3 Detailed characteristics of included studies reporting on prenatal MRI assessment of fetuses diagnosed with isolated mild or
moderate ventriculomegaly on ultrasound
Table S4 Pooled proportions (95% CI) for rate of additional anomalies detected only on MRI in fetuses diagnosed with isolated VM on
dedicated neurosonography, according to severity
Table S5 Pooled proportions (95% CI) for rate of additional anomalies detected only on MRI in fetuses diagnosed with isolated VM on
dedicated neurosonography, according to laterality of VM
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